# Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR

> **NCT06689839** · NA · RECRUITING · sponsor: **EnCompass Technologies, Inc.** · enrollment: 500 (estimated)

## Conditions studied

- Aortic Stenosis Treated With TAVI
- Aortic Diseases

## Interventions

- **DEVICE:** F2 Filter and Delivery System
- **PROCEDURE:** Transcatheter Aortic Valve Replacement (TAVR)

## Key facts

- **NCT ID:** NCT06689839
- **Lead sponsor:** EnCompass Technologies, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-09
- **Primary completion:** 2026-12
- **Final completion:** 2027-01
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-11-20

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06689839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06689839, "Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR". Retrieved via AI Analytics 2026-09-28 from https://api.ai-analytics.org/clinical/NCT06689839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*